https://www.sanofi.com/fr/investisseurs/conferences-de-brokers/2024-leerink-partners-polarxpress
leerink partnerssanofi
https://www.marketscreener.com/news/leerink-partners-adjusts-price-target-on-merck-to-124-from-114-maintains-outperform-rating-ce7e58dcd18ff126
Merck has an average rating of overweight and mean price target of $114.35, according to analysts polled by FactSet. ...
leerink partnerspricetargetmerck
https://www.marketscreener.com/news/leerink-partners-adjusts-price-target-on-revvity-to-140-from-120-maintains-outperform-rating-ce7e58ded08df624
Revvity has an average rating of overweight and mean price target of $114.19, according to analysts polled by FactSet. ...
leerink partnerspricetargetrevvity
https://www.biospace.com/karyopharm-to-participate-at-barclays-26th-annual-global-healthcare-and-leerink-partners-global-biopharma-conferences
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) today announced that the Company's senior management team will participate in the Leerink Partners Global Biopharma...
global healthcareparticipatebarclaysannual